Chemical Genomics Paradigm for Epigentic Regulation
Chemical Genomics Paradigm for Epigentic Regulation
批准号:
8426134
负责人:
Ming-Ming Zhou
金额:
$47.41万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-24 至 2015-01-31
关键词:
AffinityBindingBioinformaticsBiologicalBiologyBiomedical ResearchBromodomainCell Fate ControlCellsChemicalsChromatinChromatin StructureCommunitiesDNADNA Modification ProcessDevelopmentDiseaseEmbryoEpigenetic ProcessEquilibriumExcisionGene ExpressionGenesGenetic TranscriptionGenomicsGoalsHealthHeartHistonesHumanHuman BiologyHuman GenomeInformaticsInterdisciplinary StudyInvestigationKnowledgeLigandsLinkLysineMethodologyMethodsModificationMolecularOutcomePHD FingerPathway interactionsPhasePhysiologicalProductionProteinsPublicationsRNA InterferenceReaderRegulationReportingResearchResearch PersonnelResearch Project GrantsSomatic CellStem cellsStimulusStructureTechnologyTertiary Protein StructureTestingTranscriptional RegulationValidationbasec-myc Genescell behaviorcell transformationcell typecomplex biological systemsdesignempoweredepigenomeepigenomicsinduced pluripotent stem cellinhibitor/antagonistinsightknockout geneknowledge basemultidisciplinaryprogramsresponseself-renewalsmall moleculesmall molecule librariesstemstem cell biologythree dimensional structuretooltranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Gene expression of the human genome in response to physiological and environmental stimuli is dictated by chemical modifications of the DNA and the DNA-packing histones, as well as transcription factors. This highly complex biological system that operates with a large number and different combinations of epigenetic modifications has defied our full investigation of its basic mechanisms with existing tools. A prime example is the biology of stem cell in which a balance between self-renewal and differentiation lies at the heart of how its chromatin structure enacts different transcriptional programs to instruct pluripotent cell behavior. Yamanaka's reprogramming of somatic cells to induced pluripotent stem cells using four transcription factors Oct3/4, Sox2, Klf4 and c-Myc (OSKM) highlights the ultimate control of cell fate by gene transcription. However, the questions on how the OSKM factors transform the cell's epigenome and how their own expression are controlled during stem cell self-renewal and differentiation are yet to be answered. The functional effects of epigenetic modifications are realized by the binding of epigenome readers such as the acetyl-lysine binding bromodomain and the methyl-lysine binding chromodomain that are present in transcription and chromatin regulators. Unlike RNA interference or gene knockout that entails the removal of an entire protein along with all its interactions, a small-molecule inhibitor (chemical probe) could remove a single interaction in a multi-domain protein in its endogenous form, thus providing a much finer tool for the temporal perturbation of the complex biological system. In this multidisciplinary research project, we will develop high affinity and selective chemical probes for a selected group of bromodomains and chromodomains that function in stem cell biology, either individually (i.e. single-target probes) or as a group in a biological pathway (i.e. multi-target probes). Our study uses a coherent set of structural/chemical biology and chromatin/stem cell biology methods being developed by our key investigators with multidisciplinary expertise. We will also develop an Epigenome Reader KnowledgeBase to aid target profiling, design, production and validation of new chemical probes. To attain these goals, we will achieve the following three specific aims: (1) Target profiling of epigenome readers based on their epigenetic functions; (2) Probe development using target structure-guided strategy; and (3) Probe validation in a functional context of gene transcriptional regulation in stem cell biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transcriptional Mechanism of BRD4 in Solid Tumor
-
批准号:10358485
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2019
-
负责人:Ming-Ming Zhou
-
依托单位:
Transcriptional Mechanism of BRD4 in Solid Tumor
-
批准号:10089421
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2019
-
负责人:Ming-Ming Zhou
-
依托单位:
Transcriptional Mechanism of BRD4 in Solid Tumor
-
批准号:9883764
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2019
-
负责人:Ming-Ming Zhou
-
依托单位:
Transcriptional Mechanism of BRD4 in Solid Tumor
-
批准号:10582673
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2019
-
负责人:Ming-Ming Zhou
-
依托单位:
Transcriptional Mechanism of BRD4 in Solid Tumor
-
批准号:10025103
-
项目类别:
-
资助金额:$11.87万
-
财政年份:2019
-
负责人:Ming-Ming Zhou
-
依托单位:
Mechanism of BET Proteins in Th17 Cell Differentiation
-
批准号:9241951
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2016
-
负责人:Ming-Ming Zhou
-
依托单位:
Molecular Interactions and Regulation of p53
-
批准号:8288894
-
项目类别:
-
资助金额:$28.01万
-
财政年份:2011
-
负责人:Ming-Ming Zhou
-
依托单位:
Molecular Interactions and Regulation of p53
-
批准号:7896964
-
项目类别:
-
资助金额:$20.86万
-
财政年份:2010
-
负责人:Ming-Ming Zhou
-
依托单位:
Chemical Genomics Paradigm for Epigenetic Regulation
-
批准号:7943541
-
项目类别:
-
资助金额:$59.73万
-
财政年份:2009
-
负责人:Ming-Ming Zhou
-
依托单位:
Chemical Genomics Paradigm for Epigentic Regulation
-
批准号:8608445
-
项目类别:
-
资助金额:$92.74万
-
财政年份:2008
-
负责人:Ming-Ming Zhou
-
依托单位:
Chemical Genomics Paradigm for Epigenetic Regulation
-
批准号:8332917
-
项目类别:
-
资助金额:$93.74万
-
财政年份:2008
-
负责人:Ming-Ming Zhou
-
依托单位:
Chemical Genomics Paradigm for Epigentic Regulation
-
批准号:8237707
-
项目类别:
-
资助金额:$94.63万
-
财政年份:2008
-
负责人:Ming-Ming Zhou
-
依托单位:
Chemical Genomics Paradigm for Epigenetic Regulation
-
批准号:7691399
-
项目类别:
-
资助金额:$91.93万
-
财政年份:2008
-
负责人:Ming-Ming Zhou
-
依托单位:
Chemical Genomics Paradigm for Epigenetic Regulation
-
批准号:7930711
-
项目类别:
-
资助金额:$93.74万
-
财政年份:2008
-
负责人:Ming-Ming Zhou
-
依托单位:
Chemical Genomics Paradigm for Epigenetic Regulation
-
批准号:7523730
-
项目类别:
-
资助金额:$93.67万
-
财政年份:2008
-
负责人:Ming-Ming Zhou
-
依托单位:
Structure and Mechanism of Pathogen SET Domain HKMTs
-
批准号:7489881
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2006
-
负责人:Ming-Ming Zhou
-
依托单位:
Structure and Mechanism of Pathogen SET Domain HKMTs
-
批准号:7268844
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2006
-
负责人:Ming-Ming Zhou
-
依托单位:
Structure and Mechanism of Pathogen SET Domain HKMTs
-
批准号:7142849
-
项目类别:
-
资助金额:$25.97万
-
财政年份:2006
-
负责人:Ming-Ming Zhou
-
依托单位:
Structure and Mechanism of Pathogen SET Domain HKMTs
-
批准号:7669158
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2006
-
负责人:Ming-Ming Zhou
-
依托单位:
AUTOMATIC LIQUID HANDLING SYSTEM: CANCER
-
批准号:7166695
-
项目类别:
-
资助金额:$6.98万
-
财政年份:2005
-
负责人:Ming-Ming Zhou
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: